Cytune Pharma's Acquisition

Cytune Pharma was acquired by PPF Group on August 30, 2018.

Cytune Pharma is developing a portfolio of immunotherapeutic agents to treat primarily cancer. Cytune's compound, CYP 0150, is a human interleukin-15 linked to its effector.…

Articles about Cytune Pharma's Acquisition: